Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel analysts maintained a Buy rating on Evolus (NASDAQ:EOLS) with a steady price target of $25.00. The firm's positive ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Investment analysts at Stifel Canada issued their FY2024 earnings estimates for TELUS International (Cda) in a research note issued on Wednesday, January 15th. Stifel Canada analyst S. Sukumar ...

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.

Investment dealer Eight Capital has announced plans to wind down its operations, marking a significant shift in Canada’s ...

In a report released today, Stephen Soock from Stifel Nicolaus maintained a Buy rating on Prime Mining (PRMNF – Research Report), with a price ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.